Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

AIDS Researchers Open Door to Activists


United Press International (07/11/90)

Bethesda, Md.--For the first time, the AIDS Clinical Trials Group (ACTG) of the National Institute of Allergy and Infectious Diseases, the group conducting government-sponsored AIDS trials nationwide, yesterday opened its doors to AIDS activists and patients. Activists from the AIDS Coalition to Unleash Power (ACT UP) have been among the most vocal critics of the ACTG's custom of meeting every three months in closed-door sessions to plan how human trials of AIDS therapies will be conducted and to report on progress. The researchers, however, opened their doors to ACT UP and the public yesterday, with Anthony Fauci, director of the research effort, urging scientists not to be threatened by the questions of activists and patients.


Copyright © 1990 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

Information in this article was accurate in July 11, 1990. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.